These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29843394)

  • 1. Racial Disparities and Preventive Measures to Renal Cell Carcinoma.
    Sims JN; Yedjou CG; Abugri D; Payton M; Turner T; Miele L; Tchounwou PB
    Int J Environ Res Public Health; 2018 May; 15(6):. PubMed ID: 29843394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.
    Callahan CL; Schwartz K; Corley DA; Ruterbusch JJ; Zhao WK; Shuch B; Graubard BI; Rothman N; Chow WH; Silverman DT; Purdue MP; Hofmann JN
    Cancer Causes Control; 2020 Jan; 31(1):85-93. PubMed ID: 31782041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International variations and trends in renal cell carcinoma incidence and mortality.
    Znaor A; Lortet-Tieulent J; Laversanne M; Jemal A; Bray F
    Eur Urol; 2015 Mar; 67(3):519-30. PubMed ID: 25449206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking and renal cell carcinoma risk among black and white Americans: effect modification by hypertension and obesity.
    Cote ML; Colt JS; Schwartz KL; Wacholder S; Ruterbusch JJ; Davis F; Purdue M; Graubard BI; Chow WH
    Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):770-9. PubMed ID: 22426145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.
    Chow WH; Shuch B; Linehan WM; Devesa SS
    Cancer; 2013 Jan; 119(2):388-94. PubMed ID: 23147245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of reproductive factors and renal cell carcinoma among black and white women in the United States.
    Purdue MP; Colt JS; Graubard B; Davis F; Ruterbusch JJ; Digaetano R; Karami S; Wacholder S; Schwartz K; Chow WH
    Cancer Causes Control; 2011 Nov; 22(11):1537-44. PubMed ID: 21866373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.
    Hofmann JN; Schwartz K; Chow WH; Ruterbusch JJ; Shuch BM; Karami S; Rothman N; Wacholder S; Graubard BI; Colt JS; Purdue MP
    Cancer Causes Control; 2013 Jan; 24(1):167-74. PubMed ID: 23179659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparity in incidence patterns and outcome of kidney cancer.
    Vaishampayan UN; Do H; Hussain M; Schwartz K
    Urology; 2003 Dec; 62(6):1012-7. PubMed ID: 14665346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States.
    Yedjou CG; Tchounwou PB; Payton M; Miele L; Fonseca DD; Lowe L; Alo RA
    Int J Environ Res Public Health; 2017 May; 14(5):. PubMed ID: 28475137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family history of cancer and renal cell cancer risk in Caucasians and African Americans.
    Karami S; Schwartz K; Purdue MP; Davis FG; Ruterbusch JJ; Munuo SS; Wacholder S; Graubard BI; Colt JS; Chow WH
    Br J Cancer; 2010 May; 102(11):1676-80. PubMed ID: 20442711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma.
    Tripathi RT; Heilbrun LK; Jain V; Vaishampayan UN
    Urology; 2006 Aug; 68(2):296-301. PubMed ID: 16904440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial difference in histologic subtype of renal cell carcinoma.
    Olshan AF; Kuo TM; Meyer AM; Nielsen ME; Purdue MP; Rathmell WK
    Cancer Med; 2013 Oct; 2(5):744-9. PubMed ID: 24403240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial/ethnic disparities in renal cell carcinoma: Increased risk of early-onset and variation in histologic subtypes.
    Batai K; Harb-De la Rosa A; Zeng J; Chipollini JJ; Gachupin FC; Lee BR
    Cancer Med; 2019 Nov; 8(15):6780-6788. PubMed ID: 31509346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival among Black and White patients with renal cell carcinoma in an equal-access health care system.
    Lin J; Zahm SH; Shriver CD; Purdue M; McGlynn KA; Zhu K
    Cancer Causes Control; 2015 Jul; 26(7):1019-26. PubMed ID: 25956269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma.
    Alam R; Rezaee ME; Pallauf M; Elias R; Yerrapragada A; Enikeev D; Fang D; Shariat SF; Woldu SL; Ged YMA; Singla N
    Urol Oncol; 2023 Nov; 41(11):460.e1-460.e9. PubMed ID: 37709565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of renal cell carcinoma subtypes in different races.
    Sankin A; Cohen J; Wang H; Macchia RJ; Karanikolas N
    Int Braz J Urol; 2011; 37(1):29-32;discussion 33-4. PubMed ID: 21385477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease and risk of renal cell carcinoma: differences by race.
    Hofmann JN; Corley DA; Zhao WK; Colt JS; Shuch B; Chow WH; Purdue MP
    Epidemiology; 2015 Jan; 26(1):59-67. PubMed ID: 25393631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors.
    Rabbani F; Herr HW; Almahmeed T; Russo P
    J Clin Oncol; 2002 May; 20(9):2370-5. PubMed ID: 11981010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
    Patel HD; Kates M; Pierorazio PM; Allaf ME
    Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.